Website Analytics Tools for Hospital Systems

By Your Health Magazine Contributor

Your Health Magazine Contributor

More Essential Business Tools For Marketing Healthcare Articles

Website Analytics Tools for Hospital Systems

What to evaluate, what to skip, and why most hospital marketing teams are still flying blind in 2026.

Hospital marketing has a math problem.

Freshpaint surveyed 200 senior healthcare marketers in 2026 and found that only 1% can connect more than half their ad spend to patient outcomes. One percent. Meanwhile, Gartner’s CMO Spend Survey shows marketing budgets across healthcare dropped from 9.6% of revenue to 7.2% in two years. Those two numbers are related. When a CMO cannot show the CFO what the money produced, the CFO takes some of it back.

The compliance scramble between 2022 and 2024 was necessary. Nobody regrets pulling tracking pixels off authenticated pages or getting rid of unvetted third-party scripts. But the tools that replaced them often solved the legal problem by creating a measurement problem. And now the measurement problem is the one that threatens budgets.

This article is for the hospital marketing director or VP who already handled compliance and is now staring at dashboards that do not tell them enough. Here is what the analytics market looks like, what actually matters when evaluating platforms, and where each option falls short.

The GA4 question (answered quickly)

Google will not sign a BAA for Analytics. Google’s own documentation says GA4 does not satisfy HIPAA requirements. The June 2024 AHA v. Becerra ruling, which found HHS overstepped on IP address classification, did not change this.

It gets worse soon. On June 15, 2026, Google removes the Google Signals privacy control in GA4 and shifts advertising data authority to Consent Mode’s ad_storage parameter. Hospital systems that used disabled Google Signals as a partial safeguard lose that option in weeks.

If you are still running GA4 on properties that handle or could reasonably handle PHI, stop reading this article and go fix that first. Everything below assumes you already have.

What actually separates these platforms

Most comparison articles line up eight logos and list features. That is not particularly helpful because the differences between these tools are architectural, not feature-level. Three distinctions matter more than anything on a feature matrix.

Where does the data live and who processes it?

Some platforms are the analytics engine. Your data goes in, your reports come out, nobody else touches it. Others are middleware: they sit between your website and a separate analytics tool (usually GA4), stripping PHI on the way through. The middleware approach works for compliance. It also means your analytics are only as good as whatever downstream tool receives the filtered data. Every field that gets stripped is a signal your team loses permanently.

Was it designed for healthcare or configured for it?

A general-purpose analytics tool can be made HIPAA-compliant. Plenty have been. But compliance is table stakes. The harder question is whether the tool understands your job. Does it know what a service line is? Can it report across multiple facilities? Does it produce the kind of metrics a hospital CMO presents to a board, or does it give you page views and bounce rates and leave the rest to you?

Does AI run on the full dataset or the filtered one?

Every vendor is adding AI features. The question nobody asks is what data the AI has access to. If your analytics platform is a proxy that strips data before sending it downstream, then any AI layer sits on the reduced dataset. AI on complete first-party data and AI on proxy-filtered data produce very different outputs.

The platforms, organized by what they actually are

Purpose-built for hospital marketing

LightTrail (lighttrail.com) is built from the ground up for healthcare marketing teams. It replaces the typical stack of five or six compliance vendors with a single product under one BAA. First-party data collection on HIPAA-aligned infrastructure, analysis inside its own environment, no data handoff to Google or anyone else.

The consolidation is the main story. Campaign attribution with full UTM tracking that does not get stripped through a proxy layer. Server-side conversion signals to Google Ads and Meta (through Google’s Conversions API and Meta’s CAPI), with a built-in test tool that verifies delivery before you rely on it for bid optimization. Funnel reports that automatically flag bottlenecks. Retention cohort analysis. Session replay with PII scrubbing. Visitor segmentation with real-time audience sizing. Automated WCAG accessibility monitoring, which none of the other platforms on this list offer.

The AI assistant, Norman, is worth understanding in detail because it is not a chatbot attached to a dashboard. Norman queries live analytics data directly. You ask a question in plain English, and it pulls from dashboards, funnels, journeys, retention data, and campaign performance to generate a report with an executive summary, trend analysis, drop-off diagnosis, and recommendations. It does follow-up questions. It generates six distinct report types per user journey, including anomaly detection and engagement pathway analysis. It exports to PDF. This is AI operating on the complete, unfiltered first-party dataset, which is a fundamentally different proposition than AI running on data that has already passed through a proxy.

For campaign measurement specifically: LightTrail preserves full UTM parameters, auto-detects untracked campaigns, pulls in paid ad metrics from Google Ads and Meta directly, and generates AI-driven campaign performance reports covering spend, impressions, clicks, conversions, and ROI. The Signals feature handles server-side event delivery with centralized logging so you can verify what was sent and confirm it landed.

Role-based access with an audit trail. Full API for programmatic access to analytics, events, and reports. BAA included with every customer.

Pricing is custom and not publicly listed. You will need a demo to evaluate fit.

Where it wins: Hospital systems that are tired of stitching together four or five tools and want a single platform where AI operates on the complete picture.

Where it does not: If you need to keep GA4 in the stack for organizational reasons, LightTrail is a replacement, not an add-on.

Freshpaint (freshpaint.io) took a different path. It started as a privacy proxy and built outward from there. The company raised $46M (including a $30.7M Series B in July 2024) and claims more than 250 healthcare organization customers. Its core product still works the same way: data flows through Freshpaint, PHI gets stripped, clean events land in GA4, Google Ads, and Meta. But the company has layered on an analytics dashboard (Freshpaint Insights), EHR-connected attribution (Ad Performance), audience segmentation (Audiences), and a consent manager.

The EHR integration is what Freshpaint talks about most, and for good reason. It connects ad clicks to attended appointments through Epic and other EHR systems. That lets marketing teams report on actual patient acquisition rather than form fills. Real capability.

Pricing is custom and not publicly listed. BAA covers 100+ integrations.

Where it wins: Hospital systems that want to keep GA4 and their existing ad platform stack while adding compliance and an attribution layer on top.

Where it does not: The architecture is still middleware. GA4 dependency persists. PHI stripping reduces data richness by design, and Freshpaint’s own documentation acknowledges that strict parity with native GA4 is not achievable. Total cost of ownership is Freshpaint plus every downstream tool you are still paying for.

General-purpose analytics that sign a BAA

Piwik PRO (piwik.pro) is a privacy-first analytics suite with four modules: analytics, tag management, consent management, and a customer data platform. It earned HIPAA certification in September 2024 through a SOC 2 Type II audit, discontinued its free plan in early 2026 (over 28,000 organizations were on it), and is pushing hard into healthcare with a Healthcare Day conference on May 26, 2026.

The interface deliberately mirrors GA4, which shortens the learning curve for teams used to Google’s reporting structure. Data sits on Microsoft Azure in US data centers, with a self-hosted option available. Healthcare clients include Shepherd Center (which reported a 40% increase in patient referrals after switching from GA4) and Rochester Regional Health, a 9-hospital system.

Business plan starts around $38/month. Enterprise plan (required for the BAA) starts around $400/month. Pricing as of May 2026 per piwik.pro/pricing.

Where it wins: Direct GA4 replacement with strong privacy controls and a BAA at a relatively transparent price point.

Where it does not: It is a general-purpose tool. No service-line reporting. No appointment attribution. No EHR connectors. No AI insight generation. You get solid web analytics under a BAA. You do not get healthcare-specific intelligence.

Enterprise-grade (and enterprise-priced)

Adobe CJA + Healthcare Shield connects web, mobile, call center, EHR, and CRM data into a unified view. Healthcare Shield is a paid add-on to Adobe Experience Platform that enables BAA coverage, customer-managed encryption keys, and extended data governance.

A distinction that catches people: standard Adobe Analytics does not qualify for a BAA. Only CJA with Healthcare Shield is on Adobe’s HIPAA-Ready Services list. Adobe expanded the program in 2025 to include “Health Data-Ready” use cases covering state consumer health data laws like Washington’s My Health My Data Act.

Pricing is custom. Implementation typically requires a systems integrator, which adds both cost and months to the timeline.

Where it wins: Large hospital systems (500+ beds, multiple facilities) already invested in the Adobe ecosystem that have the budget and SI relationship to support it.

Where it does not: The cost and complexity shut out most mid-market hospital systems. If you are running a 3-hospital system, this is probably not for you.

Product analytics (not marketing analytics)

Three platforms sign BAAs but were built for product teams building software, not for hospital marketing departments.

PostHog is open source: product analytics, web analytics, session replay, feature flags, experiments, error tracking. SOC 2 Type II. Free up to 1M events per month. BAA available on paid add-ons starting at $250/month. Pricing per posthog.com/pricing. Developer-oriented.

Mixpanel offers event-based product analytics with funnel and behavioral analysis. BAA on Enterprise plan only; pricing not publicly listed. SOC 2 Type II, ISO 27001.

Amplitude does behavioral analytics with warehouse-native deployment on Snowflake and Databricks. BAA on Enterprise plan; pricing not publicly listed. Some older sources claim Amplitude will not sign a BAA. Their own website says they will as of 2026.

If you are building a patient-facing app or digital health product, these are worth evaluating. If you are a hospital marketing team trying to connect ad spend to patient volume, they are not the right category.

Self-hosted

Matomo is open-source web analytics. The cloud version is not HIPAA-compliant and Matomo will not sign a BAA for it. The only path is self-hosted On-Premise on your own HIPAA-compliant infrastructure, with your IT team handling installation, encryption, hardening, patching, and upkeep. Total cost of ownership often exceeds cloud alternatives once DevOps hours are factored in. Best for organizations with strong IT teams and a hard requirement for full data sovereignty.

Regulatory context that matters right now

This is not a regulatory deep-dive, but a few developments are directly relevant to your analytics decision.

The AHA v. Becerra ruling in June 2024 narrowed one specific HIPAA trigger: HHS overstepped when it classified IP addresses on unauthenticated public health pages as PHI. HHS dropped its appeal in August 2024. This did not make GA4 compliant. It did not affect authenticated pages. It did not change FTC enforcement authority. It did not override state privacy laws.

State-level enforcement is accelerating. Washington’s My Health My Data Act has active class action litigation (first suit filed February 2025). Nevada, Connecticut, and Virginia enacted similar consumer health data protections. New York’s version passed the legislature but was vetoed in December 2025.

OCR closed over 40 enforcement actions across 2024 and 2025, totaling $6.6M. For 2026, OCR added tracking technology on authenticated pages, 42 CFR Part 2 substance use disorder regulations (civil penalties effective February 2026), and parental access to minor children’s records to its enforcement priorities.

The FTC does not need HIPAA to act. BetterHelp paid $7.8M. Cerebral’s CEO was named personally in a consent decree. Hospital systems with sloppy data flows face exposure from multiple directions simultaneously.

Making the decision

There is no single right answer here because hospital systems are not all in the same situation. A 2-hospital system with a $50K marketing analytics budget and no existing vendor relationships has a completely different decision than a 12-hospital system locked into Adobe Experience Platform with a dedicated SI partner.

But the wrong answer is clear: staying on GA4 for properties that touch PHI, or running a compliant proxy setup that gives your team safe data but not useful data.

The gap between “compliant” and “useful” is where hospital marketing teams are losing their budgets. Close that gap and you can show the CFO what the money produced. Keep it open and next year’s budget will be smaller than this year’s.

To see what healthcare-specific analytics looks like in practice, explore LightTrail at lighttrail.com.